Testing a Multilevel, Culturally Appropriate Lifestyle Intervention For Hispanic Patients With Me… (NCT07199491) | Clinical Trial Compass
By InvitationNot Applicable
Testing a Multilevel, Culturally Appropriate Lifestyle Intervention For Hispanic Patients With Metabolic Dysfunction-associated Steatotic Liver Disease
United States64 participantsStarted 2026-01-29
Plain-language summary
The purpose of this study is to understand if a behavioral lifestyle intervention called the Healthy Liver/Hígado Sano program can help Hispanic/Latino patients with metabolic dysfunction associated steatotic liver disease (MASLD), also known as non-alcoholic fatty liver disease (NAFLD), lose weight and improve their liver health
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Self-reported Hispanic/Latino
* Have been diagnosed with MASLD
* Be an adult \>= 18 years of age
* Able to speak English or Spanish
* Have a working telephone number
* Have access to internet, either on their phone, at home or at some other location convenient to the participant
* Have a family member willing to attend all sessions
Exclusion Criteria:
* Taking a GLP-1 receptor agonist or dual agonist at the time of enrollment, or plans to being taking one in the next 6 months
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this trial is specifically for Hispanic patients with MASLD and is enrolling by invitation only, can you tell me if I might be eligible and whether you could refer or connect me to the research team?
2This study is measuring things like recruitment, retention, and participant satisfaction rather than clinical outcomes like liver health improvement — does that mean it's too early to know if this lifestyle intervention actually helps MASLD, and what would that mean for me if I joined?
3The trial focuses on a culturally appropriate lifestyle intervention, so what kinds of changes to diet, exercise, or daily habits might be involved, and realistically how much time and effort would that require from me each week?
4Would participating in this study delay or interfere with any standard treatments I might already be a candidate for, like medication or nutrition counseling for my liver disease?
5If this trial is still in a feasibility stage, are there other proven or guideline-based lifestyle programs for MASLD that I should consider first while we wait to see what this research finds?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Recruitment Feasibility
Timeframe: Baseline
2
Retention
Timeframe: 6 months, 12 months
3
Adherence
Timeframe: 6 months
4
Participant satisfaction
Timeframe: 6 months
Trial details
NCT IDNCT07199491
SponsorThe University of Texas Health Science Center, Houston